Arkstone, an innovative biotechnology company democratizing infectious disease expertise and fighting antimicrobial resistance, has been acquired by global healthcare private equity firm ARCHIMED, which now holds a majority stake. BOCA RATON, Fla., July 30, 2025 /PRNewswire/ -- Arkstone,...
Hence then, the article about archimed acquires a majority stake in arkstone forging a powerful partnership to accelerate global healthcare innovation and dominate the emerging ai driven clinical decision support market was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( ARCHIMED Acquires a Majority Stake in Arkstone, Forging a Powerful Partnership to Accelerate Global Healthcare Innovation And Dominate the Emerging AI-Driven Clinical Decision Support Market )
Also on site :
- ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
- Shanghai Electric hlási silné výsledky za rok 2025 - nové objednávky na rekordnej úrovni
- Akemona to Power Upcoming Tokenized Offering for Industrialized Innovation Impact Portfolio I